Showing results (1-10 of 270) with videos related to
Sort By:
Pageof 27
Clinical Kidney Journal|June 25, 2024
Ten tips on immunosuppression in primary membranous nephropathyHernando Trujillo, Fernando Caravaca-Fontán, Manuel PragaAmerican Journal of Nephrology|July 7, 2021
The Forgotten Antiproteinuric Properties of DiureticsHernando Trujillo, Fernando Caravaca-Fontán, Jara Caro, et al.Kidney International|February 21, 2026
The expanding role of complement inhibitors in the treatment of IgA nephropathyFernando Caravaca-Fontán, Manuel PragaKidney International Reports|January 8, 2026
Recurrence of C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis After Kidney Transplantation: Challenges and OpportunitiesJosé Enrique Ruiz-Cabello, Hernando Trujillo, Teresa Cavero, et al.Advances in Kidney Disease and Health|September 14, 2025
Management of Acute Tubulointerstitial NephritisNamrata Krishnan, Fernando Caravaca-Fontán, Manuel PragaPediatric Nephrology (Berlin, Germany)|April 13, 2026
Chronic kidney disease progression in glomerular diseases: is hematuria a key risk factor?Eduardo Gutiérrez, Ángel M Sevillano, Fernando Caravaca-Fontán, et al.Current Opinion in Critical Care|September 11, 2019
Acute kidney injury in interstitial nephritisFernando Caravaca-Fontán, Gema Fernández-Juárez, Manuel PragaNephron|May 6, 2020
Update on C3 Glomerulopathy: A Complement-Mediated DiseaseFernando Caravaca-Fontán, Laura Lucientes, Teresa Cavero, et al.Clinical Kidney Journal|December 6, 2023
Targeting complement in IgA nephropathyFernando Caravaca-Fontán, Eduardo Gutiérrez, Ángel M Sevillano, et al.Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 27, 2017
Monoclonal gammopathies of renal significanceFernando Caravaca-Fontán, Eduardo Gutiérrez, Ramón Delgado Lillo, et al.Pageof 27